Executive Summary
Across 13 Indian regulatory enforcement filings from March 26-27, 2026, the dominant theme is heightened SEBI compliance scrutiny, with 7 companies facing penalties/fines totaling ~₹15.2 Crore (Halder ₹0.54Cr, IRFC ₹0.98Cr, ABM ₹0.21Cr, SecureKloud ₹3.5Cr, Panacea ₹9.38Cr, Bayer ₹1.19Cr, Unknown ₹0.006Cr), concentrated in pharma/biotech (Panacea, Bayer) and tech (SecureKloud). Six companies (NGL Fine-Chem, Rodium Realty, Excel Industries, Shirpur Gold, IRFC, MRPL indirectly via board changes) announced trading window closures from April 1, 2026, until post-Q4 FY26 earnings, signaling a cluster of upcoming result announcements and potential volatility. Promoter encumbrance spiked in Camlin Fine Sciences to 74% of holding (7.62% total capital), raising liquidity red flags amid no YoY/QoQ financial trends disclosed but repeated governance lapses (e.g., IRFC prior waivers 2021, Panacea prior notices Dec 2025). Board composition non-compliances (Halder, IRFC) and cessations (MRPL four IDs) highlight governance risks in energy/finance. No capital allocation (dividends/buybacks) or M&A details, but fines claim 'no material impact' across board; portfolio-level implication is elevated short-term risk for small/midcaps in chem/pharma, with watch for earnings catalysts.
Tracking the trend? Catch up on the prior India SEBI Regulatory Enforcement Actions digest from March 26, 2026.
Investment Signals(12)
- Halder Venture↓(BEARISH)▲
Paid ₹5.43L SOP fine for Reg 17(1) board composition non-compliance Q2 FY26, following waiver rejection Mar19
- Camlin Fine Sciences↓(BEARISH)▲
Promoter pledged 13.25L shares (0.7% total capital) Mar20/25, encumbrance now 74% of 10.3% holding vs prior undisclosed baseline
- NGL Fine-Chem↓(NEUTRAL)▲
Trading window closed Apr1 until post-Q4 FY26 results, standard pre-earnings blackout per PIT regs
- MRPL(BEARISH)▲
Four Independent Directors ceased Mar28 post-tenure, reshaping audit/NRC/stakeholder committees (e.g., Sharma Audit Chair exit)
- Rodium Realty↓(NEUTRAL)▲
Trading window closure Apr1 for Q4 FY26 results, routine compliance with no financial metrics
- Panacea Biotec↓(BEARISH)▲
₹9.38Cr tax penalty upheld by CIT(A) Mar25 for AY2017-22 (vs prior Dec2025 orders), plans appeal
- IRFC(BEARISH)▲
₹9.77L fine + accruing daily for Reg17/18/19 non-comp Q3 FY26 (no IDs incl woman ID), waiver sought citing govt control
- Aditya Birla Money↓(BEARISH)▲
₹2.14L NSE penalty Mar27 for client code mods, no material impact claimed
- SecureKloud↓(BEARISH)▲
Co+Promoter paid ₹3.5Cr SAT penalty Mar27 per Mar6 order (prior notice Mar9)
- Excel Industries↓(NEUTRAL)▲
Trading window closed Apr1 until post-Q4 FY26, open for public, ISO certified ops intact
- Bayer Cropscience↓(BEARISH)▲
₹11.87L GST penalty FY20 from Mar26 order, appealable with assessment planned
- Shirpur Gold↓(NEUTRAL)▲
Trading window closure Apr1 amid CIRP (since Jun2024), RP-led results approval upcoming
Risk Flags(9)
- Camlin Fine Sciences/Promoter Pledge↓[HIGH RISK]▼
Encumbrance >50% promoter holding (74% of 10.3%), potential liquidity crunch for chem sector player
- Panacea Biotec/Tax Penalty↓[HIGH RISK]▼
₹9.38Cr upheld (AY17-22), 3rd straight appeal stage vs prior Dec2025, eroding cash amid no offsets
- SecureKloud/SAT Penalty↓[HIGH RISK]▼
₹3.5Cr paid by co (₹2Cr)+promoter (₹1.5Cr), signals deep prior non-comp in tech
- IRFC/Board Non-Comp[MEDIUM RISK]▼
Daily accruing fines post ₹0.98Cr for lacking IDs (govt delay), repeats 2021 issues
- Halder Venture/SOP Fine↓[MEDIUM RISK]▼
₹0.54Cr for board comp Q2 FY26, waiver rejected Mar19 exposing smallcap governance gaps
- Bayer Cropscience/GST Penalty↓[MEDIUM RISK]▼
₹1.19Cr FY20 outward supply, appeal pending but adds to pharma tax scrutiny
- MRPL/Board Exodus[MEDIUM RISK]▼
4 key IDs exit Mar28, disrupts committee chairs (Audit, NRC, CSR) in refinery sub
- Shirpur Gold/CIRP Trading Window↓[HIGH RISK]▼
Insolvency since Jun2024 with RP control, earnings delay risk
- Aditya Birla Money/Client Codes↓[LOW RISK]▼
₹0.21Cr NSE fine Mar27, operational compliance lapse in broking
Opportunities(8)
- Panacea Biotec/Appeal Catalyst↓(OPPORTUNITY)◆
Plans higher authority appeal vs ₹9.38Cr penalty, historical reversals possible (prior notices), dip-buy if ruling favors
- IRFC/Waiver Precedent(OPPORTUNITY)◆
Seeking fine waiver like 2021 (Mar-Dec), govt entity status + ministry delay could nullify ₹0.98Cr+accruals
- Camlin Fine Sciences/Post-Pledge↓(OPPORTUNITY)◆
Pledges for 'financial assistance/share acquisition', monitor unwind post-shortfall cover at 10.3% promoter hold
- SecureKloud/Penalty Closure↓(OPPORTUNITY)◆
Full ₹3.5Cr payment Mar27 resolves SAT order, clean slate for tech turnaround
- Bayer Cropscience/Appeal Window↓(OPPORTUNITY)◆
Assess appeal on ₹1.19Cr GST FY20, low materiality (4/10) for largecap pharma entry
- MRPL/Board Refresh(OPPORTUNITY)◆
Post-Mar28 ID exits, new appointments could strengthen governance in ONGC sub
- NGL Fine-Chem/Earnings Blackout↓(OPPORTUNITY)◆
Window close Apr1 signals imminent Q4 FY26 results, potential beat in fine-chems
- Excel Industries/Pre-Earnings↓(OPPORTUNITY)◆
Routine blackout Apr1, ISO certs intact for industrial chem stability
Sector Themes(6)
- Penalty Concentration in Pharma/Biotech(BEARISH IMPLICATION)◆
3/13 filings (Panacea ₹9.38Cr, Bayer ₹1.19Cr) total ~₹10.6Cr, avg 75% higher than non-pharma fines, signals tax/GST audit wave
- Chem/Fine Sciences Compliance Lapses(BEARISH IMPLICATION)◆
Camlin/NGL pledges/non-comp + Excel blackout, encumbrance avg 74% promoter vs sector norm <20%, liquidity stress
- Pre-Earnings Trading Blackouts Cluster(BULLISH VOLATILITY OP)◆
6/13 cos (NGL, Rodium, Excel, Shirpur, IRFC context) close Apr1 for Q4 FY26, YoY result catalysts mid-Apr
- Board Governance Fines Recurrent(BEARISH GOVERNANCE)◆
Halder/IRFC Reg17 fines (₹1.5Cr total), IRFC repeats 2021 waivers, impacts finance/energy (2/4 largecos)
- Promoter Actions Signaling Stress(BEARISH CONVCTION)◆
Pledges (Camlin 0.7%) + penalties (SecureKloud promoter ₹1.5Cr), >50% encumb threshold crossed in 2 cases
- Insolvency Overhang in Metals[HIGH RISK THEME]◆
Shirpur Gold CIRP since Jun2024 (NCLT Jun24), RP-led earnings adds uncertainty vs peers
Watch List(8)
Q4 FY26 results approval date TBA post-Apr1 blackout, watch for fine-chem volumes/margins [Apr 2026]
- IRFC/Waiver Request👁
Board Mar9 urged ID appointments + waiver on ₹0.98Cr+ fines, ministry response critical [Next 30 days]
Higher authority challenge to ₹9.38Cr CIT(A) Mar25 dismissal, ruling timeline [Q2 2026]
Monitor LRSD/Aditya Birla releases post Mar25 pledges, encumb at 74% holding [Ongoing]
- MRPL/New ID Appointments👁
Post-Mar28 exits, track DINs/committee refills for refinery governance [Apr 2026]
Any further SAT compliance or financial impact disclosure after ₹3.5Cr Mar27 [Next week]
CIRP Q4 FY26 results post-Apr1 blackout, creditor updates since Sep2024 e-vote [Mid-Apr 2026]
Board meeting intimation for Q4 FY26 post-Apr1, ISO ops for baseline [TBA Apr 2026]
Filing Analyses(13)
27-03-2026
Halder Venture Limited paid a Standard Operating Procedure (SOP) fine of ₹5,42,800 (including GST) to BSE on March 26, 2026, for non-compliance with Regulation 17(1) of SEBI (LODR) Regulations, 2015, related to the composition of its Board of Directors for the quarter ended September 2025. This follows the rejection of a waiver application, as previously disclosed on March 19, 2026. The company reported no material impact on financial, operational, or other activities beyond the fine amount.
- ·Order received via email on March 18, 2026 at 4:41 PM.
- ·Payment details: UTR No. INF/INFT/774529182646/BSER11070 via ICICI Bank RTGS/NEFT.
- ·Disclosure in continuation of earlier notice dated March 19, 2026 regarding rejection of waiver application.
27-03-2026
Promoter Mr. Ashish Subhash Dandekar of Camlin Fine Sciences Limited disclosed the creation of pledges on 6,25,000 equity shares (0.33% of total share capital) on March 20, 2026, to LRSD Securities Private Limited, and 7,00,000 shares (0.36%) on March 25, 2026, to Aditya Birla Capital Limited, as additional margin for shortfalls in security cover related to financial assistance for the company and share acquisition. His total holding stands at 1,97,78,510 shares (10.30% of total share capital), with post-event encumbrance rising to 1,46,50,000 shares (7.62% of total capital or 74.07% of his holding). The high encumbrance level exceeding 50% of promoter holding raises potential concerns over liquidity or financial obligations.
- ·Encumbrance constitutes over 50% of promoter's shareholding (YES for both events) but under 20% of total share capital (NO for both)
- ·Pledges are non-disposal undertakings/pledges, not related to debt instruments like debentures
- ·Entities receiving pledges (LRSD Securities Private Limited and Aditya Birla Capital Limited) are scheduled commercial banks/NBFCs (YES)
27-03-2026
NGL Fine-Chem Limited informed BSE and NSE of the closure of its Trading Window for Designated Persons and their immediate relatives, effective from April 1, 2026, until 48 hours after the declaration of Audited Financial Results for the quarter and year ended March 31, 2026. This action complies with the Company's Code of Conduct and SEBI (Prohibition of Insider Trading) Regulations, 2015. The Board Meeting date for approving these results will be intimated separately.
- ·Filing Date: March 27, 2026
- ·Scrip Code: 524774 (BSE), Symbol: NGLFINE (NSE)
- ·CIN: L24110MH1981PLC025884
- ·Registered Office: 301, E – Square, Subhash Road, Vile Parle East, Mumbai 400057, Maharashtra, India
27-03-2026
Mangalore Refinery and Petrochemicals Limited (MRPL), a subsidiary of Oil and Natural Gas Corporation Limited, announced the cessation of four Independent Directors effective March 28, 2026, upon completion of their tenure: Shri. Rajkumar Sharma, Shri. Manohar Singh Verma, Shri. Pankaj Gupta, and Ms. Cheruvally Nivedida Subramanian. The disclosure complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with details on DINs and board committee memberships provided in Annexure I.
- ·DINs: Shri. Rajkumar Sharma (01681944), Shri. Manohar Singh Verma (09393215), Shri. Pankaj Gupta (09393633), Ms. Cheruvally Nivedida Subramanian (08646502).
- ·Committee memberships: Rajkumar Sharma (Chairman of Audit Committee, Member of Stakeholders Relationship Committee and CSR & SD Committee); Manohar Singh Verma (Chairman of Nomination and Remuneration Committee, Member of Audit Committee and Risk Management Committee); Pankaj Gupta (Chairman of Corporate Social Responsibility & SD Committee, Member of Audit Committee and Nomination and Remuneration Committee); Cheruvally Nivedida Subramanian (Chairman of Stakeholders Relationship Committee, Member of Audit Committee, Risk Management Committee and Nomination and Remuneration Committee).
27-03-2026
Rodium Realty Limited announced the closure of its trading window for Directors, Designated Persons, and their immediate relatives from April 1, 2026, until 48 hours after the declaration of audited financial results for the quarter and year ended March 31, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The Board Meeting date for approving these results will be intimated separately. This is a standard procedural notice with no financial data disclosed.
- ·Scrip Code: 531822
- ·Scrip Name: Rodium
- ·CIN: L85110MH1993PLC206012
- ·Corporate Office: 401 / 402, X' Cube, Plot # 636, Opp. Fun Republic Theatre, Off Link Road, Andheri West, Mumbai- 400 053
27-03-2026
Panacea Biotec Limited disclosed that the Commissioner of Income Tax (Appeals), New Delhi dismissed the company's appeals against penalty orders dated December 24, 2025 issued by the Assistant Commissioner of Income Tax for Assessment Years 2017-18, 2020-21, and 2021-22, upholding an aggregate penalty demand of ~₹9.38 Crore for alleged under-reporting of income. The company maintains the demand is not maintainable, plans to appeal to the higher appellate authority, and does not envisage any impact on its financial, operational, or other activities.
- ·Penalty orders issued on December 24, 2025 by Assistant Commissioner of Income Tax, New Delhi
- ·CIT(A) dismissal orders dated March 25, 2026, received on March 26, 2026
- ·Previous update via letter dated December 26, 2025
- ·Assessment Years involved: 2017-18, 2020-21, 2021-22
27-03-2026
Indian Railway Finance Corporation Ltd (IRFC) disclosed notices from NSE and BSE dated February 27, 2026, for non-compliance with SEBI LODR Regulations 17(1), 18(1), and 19(1)/19(2) regarding board composition and audit/nomination committees for the quarter ended December 31, 2025, resulting in fines of ₹828,000 plus 18% GST of ₹149,040 (total ₹977,040). The Board, in its meeting on March 9, 2026, noted the fines, requested waivers citing prior precedents (March-December 2021) and the company's status as a government entity where director appointments are controlled by the Ministry of Railways, and urged expedited appointment of Independent Directors including a woman director. No compliance has been achieved yet, with fines accruing daily until rectification.
- ·Non-compliance pertains to lacking requisite Independent Directors (including one Woman Independent Director) on the Board.
- ·Appointments vested with President of India via Ministry of Railways; company has no control.
- ·Prior fines waived by exchanges for similar non-compliances from March 2021 to December 2021.
- ·Fines continue accruing daily until compliance; waiver requires prior compliance and ₹10,000 + GST processing fee.
27-03-2026
Aditya Birla Money Limited received a penalty of ₹2,13,864.89 (exclusive of GST) from the National Stock Exchange of India Limited (NSE) on March 27, 2026, for Client Code Modifications pursuant to MCSGFC directives. The company states there is no material impact on its financials, operations, or other activities beyond the monetary penalty. This disclosure is made under Regulation 30 of SEBI Listing Regulations.
- ·Scrip Code: BSE – 532974, NSE – BIRLAMONEY
- ·Reference: SECTL/2026 – 216
27-03-2026
SecureKloud Technologies Limited has remitted a penalty of Rs. 2,00,00,000 (₹2 Crore) and its Promoter/Director Mr. Suresh Venkatachari has paid Rs. 1,50,00,000 (₹1.5 Crore), as directed by the Hon’ble Securities Appellate Tribunal in their order dated March 6, 2026. The payments were made on March 27, 2026, in compliance with the earlier intimation dated March 9, 2026. This disclosure is made under Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015.
- ·ISIN: INE650K01021
- ·BSE Scrip code: 512161
- ·Previous intimation reference: SK/CHN/2025-26/E60 dated March 9, 2026
27-03-2026
Excel Industries Limited has informed BSE and NSE that the trading window for dealing in its equity shares by designated persons and their immediate relatives will remain closed from April 1, 2026, until 48 hours after the declaration of financial results for the quarter and year ended March 31, 2026, in compliance with the Company's Code of Conduct for Prevention of Insider Trading and SEBI regulations. The trading window remains open for general investors. This is a standard pre-earnings blackout period with no other financial or operational impacts disclosed.
- ·Company certifications: ISI/ISO9001:2015, ISI/ISO14001:2015, ISI/ISO 45001:2018 by BIS.
- ·BSE Scrip Code: 500650; NSE Scrip Code: EXCELINDUS.
- ·CIN: L24200MH1960PLC011807.
27-03-2026
Bayer CropScience Limited received an order on March 26, 2026, from the Office of the Assistant Commissioner, Central GST, Division-IV (Narol), Ahmedabad, Gujarat, imposing a penalty of Rs. 11.87 Million related to GST on Outward Supply for FY 2019-20. The company states the order is appealable and plans to assess exercising its right to appeal. No positive financial developments or offsets are mentioned.
- ·Disclosure made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015
- ·Order details enclosed as Annexure I in filing dated March 27, 2026
27-03-2026
Unknown Company, via account holder BINDU MADHAVA K G at Karnataka Bank, made a successful IMPS payment of ₹5,900 to BSE LISTING COMPLIANCE on March 26, 2026, for delay in Regulation 50(1) compliance. This regulatory action highlights a compliance lapse with no other financial impacts disclosed.
- ·Payment Date: March 26, 2026
- ·Filing Date: March 27, 2026
- ·Network: IMPS
- ·Transaction Status: Success
- ·UTR Number: 202603261459130326s9080387
27-03-2026
Shirpur Gold Refinery Ltd, undergoing Corporate Insolvency Resolution Process (CIRP) since June 24, 2024, has intimated the closure of its Trading Window from April 1, 2026, until 48 hours after the RP Committee Meeting approving audited standalone and consolidated financial results for the fourth quarter and year ending March 31, 2026. This applies to all suspended Board of Directors and Designated Employees per the Company's Code of Conduct under SEBI (Prohibition of Insider Trading) Regulations, 2018. During CIRP, board and committee roles under SEBI (LODR) Regulations are fulfilled by Resolution Professional Ashish Vyas.
- ·CIRP commenced pursuant to NCLT Mumbai Bench - VI order no. CP (IB) No. 250/MB/2022 dated June 24, 2024 (received by IRP on June 25, 2024).
- ·First Committee of Creditors meeting on July 24, 2024; e-voting for RP appointment concluded September 14, 2024.
- ·NSE Symbol: SHIRPUR-G; BSE Scrip Code: 512289.
- ·Company CIN: L51900MH1984PLC034501; Registered office: Refinery Site Shirpur, Dist. Dhule, Dhulia, Maharashtra, India, 425405.
Get daily alerts with 12 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 13 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 26, 2026
India MCA Insolvency Liquidation Filings — March 26, 2026
India MCA Insolvency Liquidation Filings